(18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications.
about
4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CTImaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilitiesExternal radioactive markers for PET data-driven respiratory gating in positron emission tomography.Respiratory-gated PET/CT versus delayed images for the quantitative evaluation of lower pulmonary and hepatic lesions.Comparison of texture features derived from static and respiratory-gated PET images in non-small cell lung cancer(18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy.Applications and limitations of radiomicsThe clinical significance and management of lesion motion due to respiration during PET/CT scanning.Management of respiratory motion in PET/computed tomography: the state of the art.The Efficiency of Respiratory-gated 18F-FDG PET/CT in Lung Adenocarcinoma: Amplitude-gating Versus Phase-gating Methods.Utility of respiratory-gated small-animal PET/CT in the chronologic evaluation of an orthotopic lung cancer transplantation mouse model.Respiratory-gated time-of-flight PET/CT during whole-body scan for lung lesions: feasibility in a routine clinical setting and quantitative analysis.The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.(18)F-fluorodeoxyglucose positron emission tomography/computed tomography characterization of solitary pulmonary nodules: can we do better?A prospective investigation into the clinical impact of 4D-PET/CT in the characterisation of solitary pulmonary nodules.Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions.Added diagnostic value of respiratory-gated 4D 18F-FDG PET/CT in the detection of liver lesions: a multicenter study.Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases.Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results.Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
P2860
Q27012900-A69C103F-1846-4143-9068-44A3889A8FA1Q27025204-7ED603C9-AEC6-4870-9F5F-85A2A8F7E97CQ30581505-8ADDD5AF-68DB-4643-AAFB-82AA2456438BQ33706999-B8F0E2CF-02E3-4C6C-82CE-9B559180F645Q34724752-D703312F-B896-42F8-9B3A-0F1722AB8B46Q35790143-C610D13F-EC37-4172-BC59-0FFBDC009FF4Q37052862-EB99F7C7-5392-4BBD-B323-67F54BF57644Q37971475-CA279161-F276-4D53-8117-B0AD2439F09CQ38172377-4358C946-BEC3-4D8C-800C-CD84EAD60809Q38608882-7B2CB6D9-6448-435C-A250-635561696A96Q38881186-52ACF531-601D-4AF3-8257-2DF623930BE1Q39448609-61F93521-449F-46D9-90DE-7776988B68EEQ42174594-C9ED5660-866D-4AB2-BD42-A6A7694A6264Q43115169-EE952A1B-01E3-46BF-B798-C2983E176F14Q43151288-C8CDF578-7600-4CA0-9FAE-E2B430EBAE5BQ47760000-FECA6915-806C-48BC-B220-037DA5F458D7Q47797151-F6115D25-94F9-4AC2-AF50-4A07E8F08C57Q51644443-F6DEB781-1DDB-476B-8D7A-965448F4B61DQ53090057-972BFACD-7E1F-437F-B881-DD6726E8067DQ53158932-68EAD91E-351A-46A6-B554-1BA5CBC9B42F
P2860
(18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
(18)F-FDG PET-CT respiratory g ...... towards clinical indications.
@en
type
label
(18)F-FDG PET-CT respiratory g ...... towards clinical indications.
@en
prefLabel
(18)F-FDG PET-CT respiratory g ...... towards clinical indications.
@en
P2093
P1476
(18)F-FDG PET-CT respiratory g ...... towards clinical indications.
@en
P2093
A A León Martín
A M García Vicente
A M Palomar Muñoz
A M Soriano Castrejón
J P Pilkington Woll
M P Talavera Rubio
V M Poblete García
P2860
P2888
P304
P356
10.1007/S12149-010-0345-2
P577
2010-02-23T00:00:00Z
P6179
1044490131